Long-Term Mole Evolution in Adults at High Melanoma Risk
Medical guidance often describes common moles as stable spots that develop during childhood and slowly diminish as people grow older. However, clinical understanding of how melanocytic nevi behave over decades in adulthood has historically had little documentation. A clinical investigation published in the Journal of the European Academy of Dermatology and Venereology evaluated how individual moles on the torso naturally evolved over more than fifteen years in adults carrying a heightened baseline risk of cutaneous malignancy.
Study Design: Tracking Decades of Skin Changes
The research, published in a 2022 paper titled The long-term evolution of melanocytic nevi among high-risk adults. in Journal of the European Academy of Dermatology and Venereology : JEADV, focused on patients attending Memorial Sloan Kettering Cancer Center (MSKCC). Investigators evaluated adults who had undergone two total body photography (TBP) imaging sessions separated by 15+ years. To evaluate natural skin changes across time and mitigate potential selection bias, the researchers included two distinct cohorts:
- A retrospective group of clinic attendees who completed two total body photography sessions spaced at least 15+ years apart.
- A prospective group consisting of consecutive patients photographed 15+ years earlier who consented to return for follow-up total body photography sessions.
Researchers compared baseline and follow-up torso images from the photographic records. The team recorded the total number of nevi, counted newly developed and disappearing lesions, tracked non-melanocytic lesions like seborrheic keratoses and actinic keratoses, recorded clinical atypia and color changes, measured lesion diameters at both visits, and analyzed dermoscopic features whenever dermoscopy was available.
What the Study Found About Adult Mole Growth
The cohort examined in The long-term evolution of melanocytic nevi among high-risk adults. included one hundred six participants. Although the average age of the patients was 40 at the baseline photographic assessment, most participants continued to develop new nevi across the follow-up period, which had a median duration of 16.4 years. The investigation yielded several specific measurements regarding lesion dynamics:
- Participants gained an average of 2.6 (SD = 4.8) new nevi between imaging visits.
- Disappearing nevi were uncommon, averaging only 0.3 (SD = 0.6) lost lesions per participant.
- An absolute increase in total nevus count occurred in 62/106 (58%) of patients, whereas only 9/106 (8%) experienced an absolute decrease in total count.
- Among individual lesions evaluated at both time points, roughly half—49% (1416/2890)—expanded in diameter by at least 25%.
- Only 6% (159/2890) of monitored lesions shrank in diameter by at least 25%.
- Most nevi displayed no significant dermoscopic changes between examinations.
- Patients with a personal history of melanoma demonstrated a higher rate of disappearing nevi, and their individual nevi were more likely to grow.
These findings challenged the classical assumption that adult moles uniformly stabilize or fade with advancing age. Instead, within this high-risk adult cohort, most nevi grew larger over time while very few disappeared entirely.
What This Study Does Not Prove
While the findings provide rare photographic tracking across more than a decade and a half, several important limitations mean the results cannot be generalized to everyone. First, this investigation represents only one single study conducted at a specialized cancer referral center (MSKCC). The study protocol evaluated individuals categorized as high-risk patients, meaning their mole biology may behave quite differently from adults in the general population.
Second, the image analysis was confined specifically to nevi located on the torso. The study did not measure long-term nevus patterns across the legs, arms, head, or neck, leaving the growth trajectory of peripheral nevi unaddressed. Furthermore, while the study documented that 49% of tracked lesions increased in diameter by at least 25%, this dimensional growth did not automatically signify malignant transformation; most lesions showed no significant dermoscopic changes. Understanding personal risk factors requires a formal evaluation through clinical risk assessment rather than assuming all expanding spots are harmful or benign.
Clinical Surveillance and Skin Safety
Because new lesions can appear throughout adulthood and existing lesions can slowly widen, relying on casual memory to spot dangerous changes is difficult. High-risk individuals benefit significantly from objective tracking methods like total body photography and serial dermoscopy under the supervision of a dermatologist. Systematic surveillance tools help clinicians differentiate between expected, slow maturation and problematic evolution that warrants a biopsy.
People concerned about changing skin spots often look into cosmetic or lifestyle adjustments, and some encounter unregulated tanning peptides like melanotan I or melanotan II promoted online. These unapproved compounds carry unknown systemic safety profiles and can trigger unpredictable shifts in skin pigment. Rather than experimenting with unapproved chemicals or trying to self-diagnose shifting spots, individuals should work directly with a board-certified dermatologist. Professional examinations combined with established monitoring routines, such as reviewing the characteristics of dysplastic nevi, offer the safest approach for managing long-term skin health.
Sources
The long-term evolution of melanocytic nevi among high-risk adults. - PubMed
Published October 31, 2026. Sources are linked in the text. See our Medical Disclaimer.